A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.

Name: A Trial to Establish the Feasibility of Combining Either the Tyrosine Kinase Inhibitor AC220,CXCR4 Inhibitor Plerixafor or HSP90 Inhibitor Ganetespib With Chemotherapy in Older Patients With Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome.
Published: 2011
License: Public Domain

Cardiff University · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

acute myeloid pilot

acute myeloid leukaemia, high risk myelodysplastic syndrome, myeloid, leukaemia, acute, myelodysplastic, pilot, cardiff, haematology, burnett, ac220, plerixafor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 833124
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.